Distance-Based Exercise to Preserve Function and Prevent Disability
Part of paid clinical trials in Dublin, California.
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study ID
- NCT07059884
- Status
- Recruiting
Conditions
- Hematopoietic and Lymphatic System Neoplasm
- Localized Malignant Solid Neoplasm
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Exercise intervention — OTHERComplete supervised TH progressive resistance exercise sessions
- Telemedicine — OTHERComplete supervised TH progressive resistance exercise sessions
- Aerobic Exercise Intervention — OTHERComplete unsupervised aerobic exercise sessions
- Dumbbell Exercise Intervention — OTHERReceive adjustable-weight dumbbells
- Accelerometry — PROCEDUREWear accelerometer
- Questionnaire Administration — OTHERAncillary studies
- Interview — OTHERAncillary studies
- Electronic Health Record Review — OTHERAncillary studies
Study Details
This clinical trial studies whether an exercise program can be successfully delivered to patients receiving treatment for cancer through virtual sessions and allow patients to exercise in their own home. Treatments for cancer can cause side effects such as fatigue and loss of strength. These side effects can make it difficult to work, take care of family, and do other things the patient wants to do. Preliminary research shows that exercise can help prevent some of these side effects, but it can be more difficult to start an exercise program when a patient is receiving cancer treatment. The exercise program in this study is delivered through telehealth (TH) video calls. The TH sessions are delivered by trained staff that supervise resistance exercises. The trained staff also provide guidance to the patient on completing unsupervised aerobic sessions on their own. This may be a successful way to deliver an exercise program and make it easier for cancer patients to exercise in their own home during treatment.
Key Dates
- Start date
- Feb 11, 2026
- Status verified
- Apr 2026
- Primary completion
- Jan 1, 2027
- Completion
- Feb 18, 2027
Study Design
- Enrollment
- 104 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Supportive care (DEFEND)Patients complete supervised TH exercise sessions consisting of progressive resistance exercise BIW and complete unsupervised aerobic exercise sessions over 30 minutes TIW until the end of SOC chemotherapy or up to a total of 6 months, whichever comes first, in the absence of disease progression or unacceptable toxicity. Patients also receive adjustable-weight dumbbells on study and wear an accelerometer throughout the study.
Primary Outcome Measure
Percentage of completed exercise sessions (Feasibility) [ Time Frame: Up to 6 months ]
Central Contacts
- Lilli Johnson773-834-4091
Locations (17)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Kaiser Permanente Dublin | Dublin | California | 94568 | Site Public Contact 877-642-4691 Jennifer M. Suga (PRINCIPAL_INVESTIGATOR) |
| Kaiser Permanente-Fremont | Fremont | California | 94538 | Jennifer M. Suga (PRINCIPAL_INVESTIGATOR) |
| Kaiser Permanente Fresno Orchard Plaza | Fresno | California | 93720 | Site Public Contact 833-574-2273 Jennifer M. Suga (PRINCIPAL_INVESTIGATOR) |
| Kaiser Permanente-Modesto | Modesto | California | 95356 | Jennifer M. Suga (PRINCIPAL_INVESTIGATOR) |
| Kaiser Permanente-Oakland | Oakland | California | 94611 | Jennifer M. Suga (PRINCIPAL_INVESTIGATOR) |
| Kaiser Permanente-South Sacramento | Sacramento | California | 95823 | Jennifer M. Suga (PRINCIPAL_INVESTIGATOR) |
| Kaiser Permanente-Santa Teresa-San Jose | San Jose | California | 95119 | Jennifer M. Suga (PRINCIPAL_INVESTIGATOR) |
| Kaiser San Rafael-Gallinas | San Rafael | California | 94903 | Jennifer M. Suga (PRINCIPAL_INVESTIGATOR) |
| Kaiser Permanente-Vallejo | Vallejo | California | 94589 | Jennifer M. Suga (PRINCIPAL_INVESTIGATOR) |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | Site Public Contact 877-442-3324 Jennifer A. Ligibel (PRINCIPAL_INVESTIGATOR) |
| Novant Health Cancer Institute - Kernersville | Kernersville | North Carolina | 27284 | Judith O. Hopkins (PRINCIPAL_INVESTIGATOR) |
| Novant Health Cancer Institute - Mount Airy | Mount Airy | North Carolina | 27030 | Judith O. Hopkins (PRINCIPAL_INVESTIGATOR) |
| Novant Health Forsyth Medical Center | Winston-Salem | North Carolina | 27103 | Judith O. Hopkins (PRINCIPAL_INVESTIGATOR) |
| UPMC Hillman Cancer Center at Butler Health System | Butler | Pennsylvania | 16001 | Kathryn Schmitz (PRINCIPAL_INVESTIGATOR) |
| IRMC Cancer Center | Indiana | Pennsylvania | 15701 | Kathryn Schmitz (PRINCIPAL_INVESTIGATOR) |
| UPMC Hillman Cancer Center - New Castle | New Castle | Pennsylvania | 16105 | Kathryn Schmitz (PRINCIPAL_INVESTIGATOR) |
| UPMC Cancer Center at UPMC Northwest | Seneca | Pennsylvania | 16346 | Site Public Contact 814-676-7900 Kathryn Schmitz (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Dublin, CA
Related Studies
- Collection and Storage of Tissue and Blood Samples From Patients With CancerRecruiting · National Cancer Institute LAO · Birmingham, Alabama
- Two Step Haplo With Radiation ConditioningPHASE2 · Recruiting · Thomas Jefferson University · Philadephia, Pennsylvania
- Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and EffectivenessPHASE1/PHASE2 · Recruiting · National Cancer Institute (NCI) · Irvine, California
- A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos StudyPHASE2 · Recruiting · Children's Oncology Group · Mesa, Arizona